Shrinking the Malaria Map

UCSF Global Health Group’s Malaria Elimination Initiative (MEI)

Malaria Elimination Group

The Malaria Elimination Group (MEG) was an independent global advisory body launched by the UCSF Global Health Group’s Malaria Elimination Initiative (MEI) in 2007 to clarify and advance the operational, technical, and financial requirements for national and regional malaria elimination. MEG was chaired by Sir Richard Feachem, Director of the UCSF Global Health Group, and convened international experts to build consensus for malaria elimination, address challenges, and advocate for malaria-elimination countries. MEG held its 11th and final meeting in India in late 2016.

Notable successes of MEG include the production of A Prospectus on Malaria Elimination and A Guide on Malaria Elimination for Policy Makers in 2009, publication of a seminal Lancet series on malaria elimination in 2010, and the signing of the Colombo Declaration on Eliminating Malaria in Sri Lanka in 2014. In 2015, due in part to MEG’s efforts in elevating the elimination agenda, three significant global documents that collectively advocate for malaria elimination and eradication were released: the World Health Organization’s (WHO) Global Technical Strategy for Malaria 2016-2030, the Roll Back Malaria Partnership’s Action and Investment to Defeat Malaria 2016-2030, and From Aspiration to Action: What Will It Take to End Malaria?

As of 2017, in light of the shifting global malaria landscape, MEG has been reengineered as the new Malaria Eradication Group (MEG 2.0) and will focus on articulating the requirements for achieving malaria eradication worldwide.

The primary goal of MEG 2.0 is to achieve global consensus on the political, financial, scientific, and operational feasibility and desirability of malaria eradication. MEG 2.0 will complement and supplement the work of WHO’s Strategic Advisory Group (SAG) on Malaria Eradication, which has developed a series of work packages to inform the malaria eradication agenda and support the WHO’s long-term commitment to eradication.

The inaugural meeting of MEG 2.0 will be held in October 2017 in California, and will establish a concrete work plan and define the group’s anticipated outputs. Sir Richard Feachem will continue his role as chair and the MEI will remain the secretariat.